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The relationship 
between cholinergic system brain 
structure and function in healthy 
adults and patients with mild 
cognitive impairment
Jessica Peter1*, Isabella Mayer2, Thomas Kammer3, Lora Minkova1, Jacob Lahr4, 
Stefan Klöppel1, Michel J. Grothe5 & Michael Orth1,2,6*
We assessed the structure–function relationship of the human cholinergic system and hypothesized 
that structural measures are associated with short-latency sensory afferent inhibition (SAI), an 
electrophysiological measure of central cholinergic signal transmission. Healthy volunteers (n = 36) 
and patients with mild cognitive impairment (MCI, n = 20) underwent median nerve SAI and 3T 
structural MRI to determine the volume of the basal forebrain and the thalamus. Patients with MCI 
had smaller basal forebrain (p < 0.001) or thalamus volumes (p < 0.001) than healthy volunteers. 
Healthy SAI responders (> 10% SAI) had more basal forebrain volume than non-responders (p = 0.004) 
or patients with MCI (p < 0.001). More basal forebrain volume was associated with stronger SAI in 
healthy volunteers (r = 0.33, p < 0.05) but not patients with MCI. There was no significant relationship 
between thalamus volumes and SAI. Basal forebrain volume is associated with cholinergic function 
(SAI) in healthy volunteers but not in MCI patients. The in-vivo investigation of the structure–function 
relationship could further our understanding of the human cholinergic system in patients with 
suspected or known cholinergic system degeneration.
The cholinergic brain in mammals anatomically consists of the four main regions basal forebrain, the brain-
stem pedunculo-pontine and lateral dorsal tegmental nuclei, a subset of thalamic nuclei as well as the striatum 
and cortex, that contain cholinergic  interneurons1. The cholinergic neurons projecting to the cortex cluster in 
the basal forebrain (Ch1 to Ch4), and their projections modulate functionally and spatially distinct regions of 
the neocortex as well as the thalamic reticular nucleus, the hippocampus and the  amygdala1–3. Basal forebrain 
volumes decline in ageing humans and are severely reduced in patients with dementia due to Alzheimer’s dis-
ease (AD), a neurodegenerative disease associated with a loss of cholinergic brain structure and their cholinergic 
projection  neurons4–6.
An important question is how cholinergic brain structure relates to brain function that is influenced by cho-
linergic projection neurons. Cholinergic pathways can be examined in-vivo using short-latency sensory afferent 
inhibition (SAI), a transcranial magnetic stimulation (TMS) paradigm that non-invasively measures the effect on 
motor cortex (M1) excitability of a preceding, conditioning sensory afferent electrical stimulus given to a periph-
eral mixed nerve above its motor  threshold7. If the interval between the peripheral nerve conditioning stimulus 
and the motor cortex TMS pulse is slightly longer than the N20 latency of somatosensory evoked potentials, 
the motor cortex becomes less excitable. The amount of SAI is reduced by the administration of scopolamine, 
a muscarinic acetylcholine receptor  antagonist8, indicating a contribution of cholinergic signal transmission to 
SAI. Basal forebrain and/or thalamus grey matter volumes can be extracted from structural  MRI9. Basal forebrain 
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and/or thalamus volumes could relate to the cholinergic influence on functional connections to cortical and 
subcortical structures including those serving sensory-motor  integration10.
We hypothesized that the structural measures of the cholinergic brain regions are associated with the response 
to SAI. We expected to find less SAI in healthy people with lower volumes of either basal forebrain or thalamus. 
In addition, we expected less SAI in patients in the prodromal stage of AD (i.e., mild cognitive impairment; MCI) 
since reduced SAI has been reported in  AD11. We also expected to find less basal forebrain volume in patients 
with MCI since atrophy in this population is well  recognized9.
Material and methods
Participants. We included 36 healthy volunteers (n = 12 Ulm and n = 24 Freiburg) and 20 patients with mild 
cognitive impairment (MCI) from the Centre for Geriatric Medicine and Gerontology at the University Medical 
Centre Freiburg. All patients with MCI needed to fulfil criteria for a diagnosis of ‘MCI due to AD’ according to 
established  criteria12. This required at least one cognitive function to be below 1.5 SD on the CERAD neuropsy-
chological  battery13. In addition, they needed to (a) report a cognitive complaint, (b) show no impairment in 
activities of daily living, (c) no dementia but (d) signs of neuronal injury (i.e., hippocampal or medial temporal 
atrophy by volumetric measures of visual rating).
Healthy volunteers were included in the study if they were 18 years or older and had no major psychiatric, 
neurological or medical disorder or a history of epilepsy or severe head injury, drug or alcohol abuse, contra-
indications to TMS, or medication. In addition, they were included when no signs of cognitive impairment were 
found (i.e., the Montreal Cognitive Assessment score was ≥ 23 as recommended by Carson and  colleagues14). 
No participant experienced any unwanted effects during or after the experiments. The Ethics Committees of 
Freiburg University and Ulm University approved the study, which we conducted according to the Declaration 
of Helsinki. All participants gave written informed consent before the study.
Magnetic resonance imaging. High-resolution structural MRI data were acquired using 3T scanners 
(Magnetom ALLEGRA in Ulm; Tim Trio in Freiburg, Siemens, Erlangen, Germany). The MRI parameters of 
the three-dimensional magnetization-prepared rapid gradient-echo (3D-MPRAGE) sequences in Ulm were as 
follows: flip angle 9°, TE = 3.67 ms; TR = 2200 ms; slice thickness = 1 mm; resolution = 1.0 × 1.0 × 1.0  mm3. The 
parameters applied in Freiburg were as follows: flip angle of 12°, TE = 2.15 ms, TR = 2200 ms, slice thickness of 
1 mm, resolution = 1.0 × 1.0 × 1.0  mm3.
MRI data were pre-processed using the Computational Anatomy Toolbox (CAT12; http:// www. neuro. uni- 
jena. de/ cat) and Statistical Parametric Mapping (SPM12, Welcome Trust Centre for Neuroimaging) implemented 
in Matlab R2016b (MathWorks, Natick, MA, USA) following the standard default procedure suggested in the 
manual. Briefly, pre-processing consisted of tissue class segmentation, registration to a standard template, spa-
tial normalization of the grey matter maps, modulation of grey matter voxel values to preserve the amount of 
volume present before normalization, and final data quality check. The standard pre-processing pipeline does 
not include any correction for head size or volume, which is why we estimated the total intracranial volume 
(TIV) of each participant as the total sum of all segmented tissue classes and used it as a covariate in all statistical 
analyses including MRI data.
Volumes of the basal forebrain cholinergic system and the thalamus. Volumes of the thalamus 
were determined using the ‘Estimate mean values inside ROI’ function in the CAT12 toolbox. For each partici-
pant CAT12 automatically performed brain structure parcellations and estimated tissue volumes of regions of 
interest (ROI) using the Neuromorphometrics brain atlas (Neuromorphometrics, Inc.) during the pre-process-
ing step. Volumes of the basal forebrain were determined using a mask obtained from a recent functional parcel-
lation study of a cytoarchitectonically-defined cholinergic basal forebrain ROI based on combined histology and 
post-mortem  MRI15. We combined volumes of the left and the right hemisphere for statistical analyses.
Electromyography recordings. We recorded surface electromyograms (EMG) from the abductor pollicis 
brevis (APB) muscle of the dominant hand using silver/silver-chloride disc surface electrodes (1 cm diameter) in 
a belly tendon montage. The EMG signal was amplified and filtered (20 Hz-2 kHz). Data (sampling rate 5 kHz) 
were digitized for off-line analysis.
Transcranial magnetic stimulation. Participants were seated in a comfortable chair. They were asked 
to relax as much as possible. Magnetic stimuli were given with a hand-held figure-of-eight coil (outer wind-
ing diameter 9 cm) connected to a High Power Magstim 200 stimulator (Magstim Co., Whitland, Dyfed, UK). 
This stimulator generates a magnetic pulse with monophasic waveform and induces a current in the brain with 
posterior-anterior flow when the coil handle is positioned at an angle of 45° pointing backwards. The optimal 
spot for APB stimulation was marked with a felt pen.
Resting motor threshold. Resting motor threshold (RMT) was defined as the minimum intensity (in % 
stimulator output) needed to evoke a motor-evoked potential (MEP) of > 50 µV in 5 out of 10 consecutive trials 
in the relaxed APB. The threshold was approached from above threshold in steps of 1% stimulator output. Once 
no MEP could be elicited the intensity was increased in steps of 1% stimulator output until a minimal MEP was 
observed. This intensity was taken as motor threshold.
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Short-latency sensory afferent inhibition (SAI). SAI of the motor cortex was examined as previously 
 described7. In brief, an MEP of ~ 1 mV peak-to-peak amplitude was elicited in the APB by TMS. This was pre-
ceded by a supra-threshold electrical stimulus given to the median nerve through bipolar surface electrodes with 
the cathode proximal to the anode. Median nerve stimulation was set at just above motor threshold to elicit an 
M-wave with about 500 µV peak-to-peak amplitude. The inter-stimulus intervals were related to the individual 
N20 latency in somatosensory evoked  potentials16 in Ulm (N20 + 2 and N20 + 4) while in Freiburg fixed inter-
stimulus interval of 20 and 21 ms were  used7.
With an inter-trial interval of 5 s 20 unconditioned stimuli (TMS stimulation alone) as well as 10 conditioned 
stimuli (TMS preceded by peripheral nerve stimulation) at each inter-stimulus interval were given in randomized 
order. Using visual feedback, trials recorded while the participants contracted the hand muscles were excluded 
online. No trials were excluded in the offline analysis. The peak-to-peak amplitude was measured, and the average 
amplitude of the conditioned MEP was expressed in percent of the average amplitude of the unconditioned MEP. 
The minimum response mean MEP amplitude at either of the inter-stimulus intervals was taken as the maxi-
mum inhibition of corticospinal excitability. We defined a response as an amount of inhibition of at least 10%16.
Data analysis. We used univariate or multivariate ANOVA to examine whether there were differences in 
demographic, electrophysiology, or structural imaging data (corrected for age and TIV) between the combined 
healthy volunteers from the Ulm and Freiburg sites, and MCI participants. For the analysis of frequencies (e.g., 
sex or SAI response) we applied either Χ2 or Fisher`s exact test. For associations between structural imaging data 
and electrophysiology data we used partial correlations while controlling for age and TIV. We used SPSS (version 
26.0; IBM Inc.; USA) for statistical analyses with p < 0.05 considered statistically significant.
Ethics approval. The Ethics Committees of Freiburg University and Ulm University approved the study.
Consent to participate. All participants gave written informed consent before the study.
Results
The healthy volunteers from the Ulm site were younger than the healthy volunteers from the Freiburg site or the 
patients with MCI (F(2,53) = 82.34, p < 0.001; Table 1); the healthy Freiburg volunteers and the MCI patients were 
of similar ages. Thus, we included age as a covariate in all statistical analyses. Patients with MCI scored lower in 
the MoCA than healthy volunteers (F(2,53) = 39.04, p < 0.001; Table 1). Post-hoc tests revealed that patients with 
MCI achieved lower scores than both healthy controls from Ulm (p < 0.001) and Freiburg (p < 0.001). Healthy 
volunteers from Ulm and Freiburg were not statistically different in their MoCA scores.
Structural data. We first examined basal forebrain and thalamus volumes as important regions of the cho-
linergic brain (Fig. 1A). Patients with MCI had significantly smaller basal forebrain (F(1, 52) = 10.01, p = 0.003, 
Fig. 1B) or thalamus volumes (F(1, 52) = 11.18, p = 0.002; Table 1, Fig. 1C) than the combined healthy volunteers. 
Post-hoc tests revealed that those differences existed not only in the combined healthy volunteer group but also 
separately between patients with MCI and healthy volunteers from Ulm (p < 0.05) or healthy volunteers from 
Freiburg (p < 0.01). There were no significant volume differences between Ulm and Freiburg for healthy volun-
teers. A larger volume of the basal forebrain was associated with a larger volume of the thalamus, when control-
ling for TIV (r(52) = 0.41, p = 0.002).
Electrophysiology. We next examined SAI as a functional measure of the cholinergic  system11. The SAI 
maximum inhibition was similar in healthy volunteers and patients with MCI (Ulm, 43.68% ± 20.13; Freiburg, 
Table 1.  Socio-demographic data of the sample and group comparison for cholinergic structure and function. 
We used multivariate ANOVA for group comparison if not stated otherwise. SD Standard deviation, HC 
Healthy controls, MCI Mild Cognitive Impairment, f/m female/male, MoCA Montreal Cognitive Assessment, 
SAI Short-latency sensory afferent inhibition, y/n number yes/number no.
Ulm (HC) Freiburg (HC) Freiburg (MCI)
p-valueMean SD Mean SD Mean SD
n (f/m) 12 (7/5) 24 (17/7) 20 (11/9) 0.55 (Fisher)
Age (years) 50.3 4.8 70.4 5.6 73.5 4.9 < 0.001
MoCA (0–30) 28.4 1.1 27.4 1.7 22.8 2.6 < 0.001
Median nerve motor threshold (mA) 8.2 1.9 9.4 2.0 8.5 1.9 0.12
Resting motor threshold (% stimulator 
output) 46.7 10.4 54.2 10.7 52.2 11.2 0.63
SAI max inhibition 0.58 0.2 0.58 0.3 0.60 0.3 0.99
SAI responder (y/n) 10/2 20/4 15/5 0.83 (Fisher)
Basal forebrain volume (ml) 3.70 0.5 3.54 0.3 3.31 0.5  < 0.001
Thalamus volume (ml) 8.97 0.9 8.77 1.0 7.51 1.0  < 0.001
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42.49% ± 27.10; MCI, 38.17% ± 26.57) and so was the number of responders to SAI (Responder/Non-responder: 
Ulm, 10/2; Freiburg 20/4; MCI 15/5). Age was not significantly associated with SAI, and neither was there a 
statistical difference between men and women.
Relationship between structure and function. We went on to ask whether there was a relation-
ship between the structural and the functional data of the cholinergic brain. For healthy volunteers, we found 
that responders to SAI had significantly more basal forebrain volume than SAI non-responders (F(1, 32) = 7.61, 
p = 0.01). In addition, more volume of the basal forebrain was associated with stronger SAI (r(36) = 0.34, p = 0.04, 
Fig. 1D). In contrast, thalamus volumes were similar in SAI responders and non-responders and did not cor-
relate with SAI as a continuous measure. Basal forebrain volumes in healthy SAI responders were significantly 
higher than in the MCI group (F(1,41) = 9.89, p = 0.003), but basal forebrain volumes of the healthy SAI non-
responders were similar to those of the MCI group.
In patients with MCI, we found no significant relationship between SAI response and basal forebrain volume 
or thalamus volume (Fig. 1E). Their basal forebrain, or thalamus, volumes were similar to those of the healthy 
SAI non-responders.
Discussion
In the current study we examined the relationship between volume of the basal forebrain, the pacemaker of the 
cholinergic system, and short-latency sensory afferent inhibition (SAI), an electrophysiological paradigm used 
to measure cholinergic brain function. In healthy volunteers SAI non-responders had significantly less basal 
forebrain volume than those that responded well, and at an individual participant level more basal forebrain 
volume was associated with better cholinergic function. Basal forebrain volumes may become smaller with 
advancing  age17. However, age did not explain the difference in SAI response associated with basal forebrain 
Figure 1.  (A) Anatomic representation of the basal forebrain cholinergic system (pink) and the thalamus 
(turquoise) regions of interest. Thalamus (B) and basal forebrain volumes (C) were smaller in patients with mild 
cognitive impairment (n = 20; red) than in healthy volunteers (n = 36; blue). In healthy volunteers, a larger basal 
forebrain was associated with stronger short-latency sensory afferent inhibition (SAI) (D) while there was no 
association in MCI patients (E). All volume data were corrected for total intracranial volume. **p < 0.01.
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volumes. Lower basal forebrain volume in SAI non-responders may therefore, independent of age, reflect a lower 
density of cholinergic projections to structures thought to be involved in the regulation of motor cortex excit-
ability. In the SAI paradigm, the influence on M1 excitability of the sensory-afferent conditioning volley could 
be mediated by direct thalamo-cortical projections to M1 or via connections from the somatosensory cortex 
(S1) to M1. Basal forebrain projections reach cortical areas including M1 and S1, at least in  mice18 in which they 
coordinate the activity of these areas with associated regions. This contributes to the regulation of cognition 
and motor command as basal forebrain projections influence functionally and spatially selective cellular signal-
ing and synaptic network  function1 and were shown to have functional connections to cortical and subcortical 
structures in humans using resting state  fMRI10. An increase of acetylcholine in the basal forebrain increases the 
cortical coding capacity as was shown for the visual cortex in  mice19. Important for sensory-motor integration 
that is being probed with SAI, cholinergic modulation of neuronal function differs between the different cortical 
layers of the somatosensory  cortex20. This includes the influence of acetylcholine on the responsiveness of cells 
in layer 4 of S1 that receives many inputs including from the thalamus. While it remains unclear which neuronal 
pathways SAI requires it is conceivable that, physiologically, there is variability in how different people process 
sensory afferent inputs to S1. If this were influenced by acetylcholine then it would be tempting to speculate that 
such differences depend, at least in part, on the density of cholinergic projections to S1 from the basal forebrain.
The thalamus is a key relay station in sensory-afferent pathways to the somatosensory cortex. The contribution 
to shaping cortical motor command extends beyond cholinergic basal forebrain projections to the cortex and 
includes the cholinergic projections to e.g., the thalamic reticular nucleus, an important regulator of thalamic 
function rich in receiving cholinergic projections from the basal  forebrain21. We therefore examined the rela-
tionship of cholinergic function (i.e., SAI) to thalamus volumes. There was no association of SAI with thalamus 
volumes. Our analyses indicate, therefore, that the basal forebrain volume plays a greater part in predicting a 
response to SAI than the thalamus volume.
We then extended our analyses to include patients with MCI given that the cholinergic brain plays an impor-
tant role in the pathogenesis of MCI and AD. In our MCI patients, as expected, basal forebrain volumes were 
smaller than in the healthy  volunteers17. This agrees with the notion that the loss of basal forebrain volume 
precedes the cortical expression of AD  degeneration22,23. However, unlike in healthy volunteers, there was no 
relationship between the structural measure of the cholinergic brain and SAI. In the MCI group, the amount 
of SAI, and the number of responders and non-responders were similar to healthy volunteers even though 
the basal forebrain, or thalamus, volumes in all MCI participants were smaller to a degree seen in healthy SAI 
non-responders. Given the data in our healthy volunteers one would have expected a greater number of SAI 
non-responders in the MCI group, in particular in light of the reports on reduced SAI in patients with  AD8. This 
was not the case suggesting that the structure–function relationship in healthy individuals differs from that in 
MCI patients. It is possible that other factors that influence SAI become more important in order to maintain 
function as long as possible as cholinergic input to thalamus and cortex changes in the wake of basal forebrain 
degeneration. However, even in patients with AD a reduction of SAI is not a consistent  finding24 suggesting that 
SAI is highly variable. Although at a population level there may be a reduction of SAI given the number of stud-
ies that have reported it in AD, the relationship is not clear and acetylcholine modulation may be more relevant 
in some individuals than others independent of whether they are healthy or affected by a neurodegenerative 
process involving the basal forebrain.
Our study has several limitations. Even though the number of participants was higher than in many other 
studies, it is possible that in light of the substantial within-participant variability of SAI the power to detect subtle 
effects at a participant level is not high enough with the number of participants we  included25. We already aimed 
to increase the number of participants by combining two cohorts from two different study sites. While the differ-
ence in age between the two cohorts is a limitation, their basal forebrain, or thalamus, volumes were similar as 
was the SAI response suggesting that age, MRI protocols or using either inter-stimulus intervals according to the 
individuals’ SEP N20 latency or fixed inter-stimulus intervals did not substantially influence the results in accord 
with current methodological  considerations26. A further limitation could be that with current MRI methodology 
we could not obtain structural information from individual thalamic nuclei so that we could not differentiate the 
thalamic reticular nucleus that receives cholinergic input or the ventral posterior nucleus as an important relay 
nucleus for somatosensory afferents. If, for instance, either of these nuclei played a prominent role in sensory 
afferent signal transmission involved in SAI while the remaining thalamus did not that specific contribution 
may have been diluted by using a volume measure of the whole thalamus. The same goes for midbrain cholin-
ergic regions such as the pedunculopontine and laterodorsal tegmental nuclei that influence striatal  function27.
Conclusion
Taken together we show that structural properties of the basal forebrain, the pacemaker of the cholinergic 
brain, are associated with the response to SAI, an electrophysiological measure of cholinergic brain function. 
The in-vivo investigation of the structure–function relationship could further our understanding of the human 
cholinergic brain. A better understanding in healthy individuals may eventually have potential in the assessment 
of patients with suspected or known degeneration of the cholinergic brain, in which SAI alone may not suffice 
as  biomarker24.
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